Skip to content

Clinical trials

Completed Ureteral Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ureteral Neoplasms Status: Completed Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20041
20051
20061
20082
20091
20101
20114
20131
20141
20152
20172
20183
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
Eli Lilly and Company2
M.D. Anderson Cancer Center2
Achieve Life Sciences1
Altor BioScience1
Astellas Pharma Global Development, Inc.1
Astellas Pharma Inc1
AstraZeneca1
Bristol-Myers Squibb1
City of Hope Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ureteral Neoplasms25
Urinary Bladder Neoplasms19
Urethral Neoplasms18
Carcinoma, Transitional Cell10
Carcinoma, Non-Small-Cell Lung3
Carcinoma, Renal Cell3
Kidney Neoplasms3
Lung Neoplasms3
Pancreatic Neoplasms3
Prostatic Neoplasms3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.